Discover how Ksilink, myriamed and their spin-off Myrtil Biotechnologies implement deep learning to enhance high-content screening and deep-tissue phenotyping to identify cardioprotective compounds in dilated cardiomyopathy by meeting us at Heart Development and Disease: From Genes to Cures Keystone Symposia at Santa Fe.
Our colleague Dr. Konstantinos Gkatzis will present poster 1029 on Monday 13/02 at 7:30 pm and will give a talk on Tuesday 14/02 at 2:45 pm.
The program is available here.
Please do not hesitate to contact us to learn more.